These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 4209885)
1. [Tolerance of high doses of a new oral antidiabetic drug]. Heinze G MMW Munch Med Wochenschr; 1974 May; 116(21):1093-4. PubMed ID: 4209885 [No Abstract] [Full Text] [Related]
2. [The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies]. Tettenborn D Arzneimittelforschung; 1974 Mar; 24(0):409-18. PubMed ID: 4408138 [No Abstract] [Full Text] [Related]
3. [Progress in oral antidiabetic therapy]. Rambert P Therapeutique; 1973 Nov; 49(9):555-6. PubMed ID: 4600034 [No Abstract] [Full Text] [Related]
4. [Testing a new antidiabetic (Glibenclamid) in hospitalized and ambulatory diabetics]. Belser F; Brögli H; Constam G; Zollikofer H Schweiz Rundsch Med Prax; 1970 Apr; 59(16):598-601. PubMed ID: 4997187 [No Abstract] [Full Text] [Related]
5. [Therapeutic trial of a new antidiabetic with vascular action: 1702 SE]. Jaillard J; Warembourg H Lille Med; 1972 Oct; 17(9):Suppl 6:1332-6. PubMed ID: 4657429 [No Abstract] [Full Text] [Related]
6. [Clinical studies on the effect of a new oral antidiabetic agent Glybenclamide (HB 419)]. Schmitt H; Höhler H; Daweke H; Jahnke K Dtsch Med Wochenschr; 1969 Apr; 94(16):824-9. PubMed ID: 5776707 [No Abstract] [Full Text] [Related]
7. [Chemistry, toxicology, pharmacodynamics and mechanism of action of biguanides]. Ezechieli S Clin Ter; 1970 Aug; 54(4):351-80. PubMed ID: 4992475 [No Abstract] [Full Text] [Related]
8. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K 4024. Parodi FA Isr J Med Sci; 1972 Jun; 8(6):888-92. PubMed ID: 5051831 [No Abstract] [Full Text] [Related]
9. [A new particularly active oral antidiabetic]. Tchobroutsky G Therapeutique; 1969 Nov; 45(9):863-5. PubMed ID: 5365409 [No Abstract] [Full Text] [Related]
10. Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 4. Toxicity and general pharmacology of 1-[p-[2-(crotonylamino)-ethyl]-phenylsulfonyl]-3-cyclohexy l-2-imino- imidazolidine (CGP 11 112). Märki F; Büch O; Delini-Stula A; Kraetz J; Petermann H; Radeke E; Schweizer A; Thomann P; Truog A Arzneimittelforschung; 1984; 34(3):247-52. PubMed ID: 6539603 [TBL] [Abstract][Full Text] [Related]
11. Clinical experience with the oral administration of the antidiabetic buformin. Sieberová R Rev Czech Med; 1971; 17(4):219-21. PubMed ID: 5122079 [No Abstract] [Full Text] [Related]
12. Oral substitutes for insulin: modern appraisal of their action and indications. Isr J Med Sci; 1972 Jun; 8(6):677-710. PubMed ID: 4626310 [No Abstract] [Full Text] [Related]
13. [Experimental and clinical pharmacology of oral antidiabetics]. Cuomo V; Marino A Clin Ter; 1972 Sep; 62(6):505-52. PubMed ID: 4674507 [No Abstract] [Full Text] [Related]
14. Hypoglycemic and antidiabetic effect of ethanolic extract of leaves of Annona squamosa L. in experimental animals. Gupta RK; Kesari AN; Murthy PS; Chandra R; Tandon V; Watal G J Ethnopharmacol; 2005 May; 99(1):75-81. PubMed ID: 15848023 [TBL] [Abstract][Full Text] [Related]